Results 41 to 50 of about 469,662 (394)

Anxiety Screening among the General Population of Latvia and Associated Factors

open access: yesMedicina, 2022
Background and Objectives: The aim of this study was to determine the point prevalence of at least mild anxiety symptoms and symptoms of generalized anxiety disorder in the Latvian general population, and to analyze the associated factors.
Vineta Viktorija Vinogradova   +3 more
doaj   +1 more source

Protocol for a randomized controlled trial examining multilevel prediction of response to behavioral activation and exposure-based therapy for generalized anxiety disorder. [PDF]

open access: yes, 2020
BACKGROUND:Only 40-60% of patients with generalized anxiety disorder experience long-lasting improvement with gold standard psychosocial interventions. Identifying neurobehavioral factors that predict treatment success might provide specific targets for ...
Abelson, J   +14 more
core   +1 more source

Prevalence Rates and Predictors of Generalized Anxiety Disorder Symptoms in Residents of Fort McMurray Six Months After a Wildfire

open access: yesFrontiers in Psychiatry, 2018
The Fort McMurray wildfire was the costliest disaster in Canadian history, with far-reaching impacts. The purpose of this paper is to examine the prevalence and risk factors of elevated generalized anxiety disorder (GAD) symptomatology in residents of ...
V. Agyapong   +12 more
semanticscholar   +1 more source

Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM1

open access: yesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView., 2023
Abstract Dynamin 1 is a GTPase protein involved in synaptic vesicle fission, which facilitates the exocytosis of neurotransmitters necessary for normal signaling. Pathogenic variants in the DNM1 gene are associated with intractable epilepsy, often manifested as infantile spasms at onset, developmental delay, and a movement disorder, and are located in ...
Davide Mei   +4 more
wiley   +1 more source

Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis [PDF]

open access: yes, 2014
Background: Anxiety disorders increase risk of future cardiovascular disease (CVD) and mortality, even after controlling for confounds including smoking, lifestyle, and socioeconomic status, and irrespective of a history of medical disorders.
Agelink   +115 more
core   +2 more sources

Effect of an Integrated Cognitive-Behavioral, Acceptance, and Commitment Intervention on Generalized Anxiety Disorder among University Students [PDF]

open access: yesJournal of Education and Community Health, 2018
Background and Objective: Regarding the importance of generalized anxiety disorder, this study aimed to investigate the effect of an integrated cognitive-behavioral, acceptance, and commitment intervention on generalized anxiety disorder among students ...
Alireza Zolfaghari   +2 more
doaj   +1 more source

Validity and reliability of the Structured Clinical Interview for Depersonalization-Derealization Spectrum (SCI-DER). [PDF]

open access: yes, 2008
This study evaluates the validity and reliability of a new instrument developed to assess symptoms of depresonalization: the Structured Clinical Interview for the Depersonalization-Derealization Spectrum (SCI-DER).
Calugi, S   +8 more
core   +2 more sources

Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory

open access: yesPLoS ONE, 2017
Objective The Generalized Anxiety Disorder scale (GAD-7) is one of the most frequently used diagnostic self-report scales for screening, diagnosis and severity assessment of anxiety disorder. Its psychometric properties from the view of the Item Response
Pascal Jordan, M. Shedden-Mora, B. Löwe
semanticscholar   +1 more source

Duloxetine in the treatment of generalized anxiety disorder

open access: yesInternational Journal of General Medicine, 2009
Alan Wright, Chad VanDenBergCenter for Clinical Research, Mercer University, Atlanta, GA, USAAbstract: Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) which is FDA approved for the treatment of generalized anxiety disorder (GAD) in ...
Alan Wright, Chad VanDenBerg
doaj   +2 more sources

Perinatal anxiety and depression amidst the COVID-19 pandemic in Dubai, United Arab EmiratesAJOG Global Reports at a Glance

open access: yesAJOG Global Reports, 2023
BACKGROUND: Pregnancy and COVID-19 increase the risk of mental health conditions. The stress of pregnancy, childbirth, and uncertainty about the global pandemic has negatively affected the obstetrical population.
Zenab Yusuf Tambawala, MS, MRCOG   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy